At the interface of innate immunity, p53 promotes NK cell-mediated tumor clearance via induction of stress ligands ULBP1/2 on tumor cells, creating an “eat-me” signal for activating receptors (NKG2D) [85]. Here, KLRK1 is linked to neoplasm.